Literature DB >> 31894741

Recent Advances in the Rational Drug Design Based on Multi-target Ligands.

Ting Yang1, Xin Sui1, Bing Yu1, Youqing Shen1, Hailin Cong1.   

Abstract

Multi-target drugs have gained considerable attention in the last decade owing to their advantages in the treatment of complex diseases and health conditions linked to drug resistance. Single-target drugs, although highly selective, may not necessarily have better efficacy or fewer side effects. Therefore, more attention is being paid to developing drugs that work on multiple targets at the same time, but developing such drugs is a huge challenge for medicinal chemists. Each target must have sufficient activity and have sufficiently characterized pharmacokinetic parameters. Multi-target drugs, which have long been known and effectively used in clinical practice, are briefly discussed in the present article. In addition, in this review, we will discuss the possible applications of multi-target ligands to guide the repositioning of prospective drugs. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Alzheimer's disease; Multitarget drugs; Parkinson's disease; cancer; neglected tropical diseases; pharmacokinetic parameters

Mesh:

Substances:

Year:  2020        PMID: 31894741     DOI: 10.2174/0929867327666200102120652

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  6 in total

1.  1-(7-Chloroquinolin-4-yl)-N-(4-Methoxybenzyl)-5-Methyl-1H-1,2, 3-Triazole-4- carboxamide Reduces Aβ Formation and Tau Phosphorylation in Cellular Models of Alzheimer's Disease.

Authors:  Mariana G Fronza; Manoela Sacramento; Diego Alves; Domenico Praticò; Lucielli Savegnago
Journal:  Neurochem Res       Date:  2022-02-15       Impact factor: 3.996

2.  Network Pharmacology and Absolute Bacterial Quantification-Combined Approach to Explore the Mechanism of Tianqi Pingchan Granule Against 6-OHDA-Induced Parkinson's Disease in Rats.

Authors:  Zhihua Liu; Jiahao Zhao; Shuyuan Yang; Yu Zhang; Lu Song; Na Wu; Zhenguo Liu
Journal:  Front Nutr       Date:  2022-05-06

3.  Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis.

Authors:  Anna Sampietro; F Javier Pérez-Areales; Paula Martínez; Elsa M Arce; Carles Galdeano; Diego Muñoz-Torrero
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-28

Review 4.  Tick Salivary Compounds for Targeted Immunomodulatory Therapy.

Authors:  Hajer Aounallah; Chaima Bensaoud; Youmna M'ghirbi; Fernanda Faria; Jindr Ich Chmelar; Michail Kotsyfakis
Journal:  Front Immunol       Date:  2020-09-23       Impact factor: 7.561

5.  Design and Synthesis of Hsp90 Inhibitors with B-Raf and PDHK1 Multi-Target Activity.

Authors:  Luca Pinzi; Francesca Foschi; Michael S Christodoulou; Daniele Passarella; Giulio Rastelli
Journal:  ChemistryOpen       Date:  2021-10-11       Impact factor: 2.630

Review 6.  Advances in Nanostructures for Antimicrobial Therapy.

Authors:  Josef Jampilek; Katarina Kralova
Journal:  Materials (Basel)       Date:  2022-03-24       Impact factor: 3.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.